首页> 外文OA文献 >Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus Using Proton Pump Inhibitors: A Systematic Review With Meta-Analysis and Trial Sequential Analysis

【2h】

Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus Using Proton Pump Inhibitors: A Systematic Review With Meta-Analysis and Trial Sequential Analysis

机译：采用质子泵抑制剂患者食管腺癌患者的风险：具有Meta分析和试验顺序分析的系统综述

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lunan Li; Huiqin Gao; Chenjing Zhang; Xiaoge Geng; Jingya Wang; Wensheng Pan; Jiyong Jing;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. [J] . Nguyen DM, Richardson P, El Serag HB Gastroenterology . 2010,第7期

机译：巴雷特食管患者的药物（NSAID，他汀类药物，质子泵抑制剂）和食道腺癌的风险。
2. Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett’s esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC) [J] . Candyce Hamel, Nadera Ahmadzai, Andrew Beck, Systematic Reviews . 2020,第1期

机译：患有或没有其他风险因素的慢性胃脂反流疾病患者的食管腺癌和癌前病症（发育不良和Barrett的食道）：两个系统评价和一个审查概述，以通知加拿大工作队对预防医疗保健的指导（CTFPHC ）
3. Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC) [J] . Progress in Artificial Intelligence . 2020,第1期

机译：患有或没有其他风险因素的慢性胃脂反流疾病患者食管腺癌和癌前病症（发育不良和Barrett的食管）：两个系统审查和审查概述，以告知加拿大工作队对预防医疗保健的指导意见（CTFPHC 的）
4. Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinoma [C] . Irina Kalatskaya World Organization for Specialized Studies on Diseases of the Esophagus World Congress . 2017

机译：Barrett食道进展过程中的主要分子改变概述食管腺癌
5. Signal Transduction in Barrett's Esophagus and Esophageal Adenocarcinoma [D] . Narendran, Nirushan Harushikesh. 2018

机译：巴雷特食管和食道腺癌中的信号转导
6. Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett’s Esophagus: A Systematic Review and Meta-Analysis [O] . Qiang Hu, Tian-Tian Sun, Jie Hong, -1

机译：质子泵抑制剂不能降低Barrett食管患者食管腺癌的风险：系统评价和荟萃分析
7. Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis. [O] . Qiang Hu, Tian-Tian Sun, Jie Hong, 2017

机译：质子泵抑制剂不会降低Barrett食管患者食管腺癌的风险：系统评价和meta分析。

Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus Using Proton Pump Inhibitors: A Systematic Review With Meta-Analysis and Trial Sequential Analysis

著录项

引文网络

相似文献

相关主题

期刊订阅